Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.20.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Stockholders' Equity Equity
Redeemable Preferred Stock
The following is a summary of the Company’s series of cumulative redeemable preferred stock issued and outstanding as of March 31, 2020. In the event of a voluntary or involuntary liquidation, dissolution or winding up of the Company, each series of preferred stock will rank on parity with one another and rank senior to the Company's common stock with respect to the payment of the dividends and the distribution of assets.
As of March 31, 2020
 
 
 
 
 
 
 
 
 
 
 
 
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Class of Stock
 
Issuance Date
 
Shares Issued and Outstanding
 
Carrying Value
 
Contractual Rate
 
Redemption Date (1)
 
Fixed to Floating Rate Conversion Date (2)
 
Floating Annual Rate (3)
Fixed-to-Floating Rate
 
 
 
 
 
 
 
 
 
 
 
 
Series A
 
March 14, 2017
 
5,750

 
$
138,872

 
8.125
%
 
April 27, 2027
 
April 27, 2027
 
3M LIBOR + 5.660%
Series B
 
July 19, 2017
 
11,500

 
278,094

 
7.625
%
 
July 27, 2027
 
July 27, 2027
 
3M LIBOR + 5.352%
Series C
 
November 27, 2017
 
11,800

 
285,585

 
7.250
%
 
January 27, 2025
 
January 27, 2025
 
3M LIBOR + 5.011%
Fixed Rate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Series D
 
July 31, 2018
 
3,000

 
74,964

 
7.750
%
 
July 31, 2018
 
N/A
 
N/A
Series E
 
July 31, 2018
 
8,000

 
199,986

 
7.500
%
 
July 31, 2018
 
N/A
 
N/A
 
Total
 
 
 
40,050

 
$
977,501

 
 
 
 
 
 
 
 
____________________
(1)
Subject to the Company’s right under limited circumstances to redeem the preferred stock earlier than the redemption date disclosed in order to preserve its qualification as a REIT or following a change in control of the Company.
(2)
For the fixed-to-floating rate redeemable preferred stock, the dividend rate will remain at an annual fixed rate of the $25.00 per share liquidation preference from the issuance date up to but not including the transition date disclosed within. Effective the conversion date and onward, dividends will accumulate on a floating rate basis according to the terms disclosed within (3) below.
(3)
On and after the fixed to floating rate conversion date, the dividend will accumulate and be payable quarterly at a percentage of the $25.00 per share liquidation preference equal to an annual floating rate of three-month LIBOR plus the spread indicated within each preferred class.

For each series of preferred stock, the Company may redeem the stock on or after the redemption date in whole or in part, at any time or from time to time. Each series of preferred stock has a par value of $0.01 per share and a liquidation and redemption price of $25.00, plus any accumulated and unpaid dividends thereon up to, but excluding, the redemption date. Through December 31, 2019, the Company had declared and paid all required quarterly dividends on the Company’s preferred stock.
Distributions to Preferred Stockholders
On March 24, 2020, as a result of the volatile market conditions related to the COVID-19 pandemic, the Company announced that it had suspended its first quarter 2020 preferred stock dividends in order to preserve liquidity and long-term stockholder value. Subsequently, on April 6, 2020, the Company’s board of directors declared its first quarter 2020 preferred stock dividends, which were paid on April 29, 2020 to stockholders of record as of April 16, 2020. Pursuant to their terms, all unpaid dividends on the Company’s preferred stock accrue without interest.
The following table details the aggregate and per-share amounts of arrearages in cumulative preferred dividends as of March 31, 2020:
(in thousands)
 
 
 
 
Class of Stock
 
Dividend Per Preferred Share in Arrears
 
Amount of Preferred Dividends in Arrears
Series A
 
$
0.507810

 
$
2,920

Series B
 
$
0.476560

 
5,480

Series C
 
$
0.453130

 
5,347

Series D
 
$
0.484375

 
1,453

Series E
 
$
0.468750

 
3,750

 
 

 
$
18,950



The following table presents cash dividends declared by the Company on its preferred stock stock from December 31, 2018 through March 31, 2020:
Declaration Date
 
Record Date
 
Payment Date
 
Cash Dividend Per Preferred Share
Series A Preferred Stock:
 
 
 
 
 
 
December 17, 2019
 
January 10, 2020
 
January 27, 2020
 
$
0.507810

September 19, 2019
 
October 11, 2019
 
October 28, 2019
 
$
0.507810

June 19, 2019
 
July 12, 2019
 
July 29, 2019
 
$
0.507810

March 19, 2019
 
April 12, 2019
 
April 29, 2019
 
$
0.507810

Series B Preferred Stock:
 
 
 
 
 
 
December 17, 2019
 
January 10, 2020
 
January 27, 2020
 
$
0.476560

September 19, 2019
 
October 11, 2019
 
October 28, 2019
 
$
0.476560

June 19, 2019
 
July 12, 2019
 
July 29, 2019
 
$
0.476560

March 19, 2019
 
April 12, 2019
 
April 29, 2019
 
$
0.476560

Series C Preferred Stock:
 
 
 
 
 
 
December 17, 2019
 
January 10, 2020
 
January 27, 2020
 
$
0.453130

September 19, 2019
 
October 11, 2019
 
October 28, 2019
 
$
0.453130

June 19, 2019
 
July 12, 2019
 
July 29, 2019
 
$
0.453130

March 19, 2019
 
April 12, 2019
 
April 29, 2019
 
$
0.453130


Declaration Date
 
Record Date
 
Payment Date
 
Cash Dividend Per Preferred Share
Series D Preferred Stock:
 
 
 
 
 
 
December 17, 2019
 
January 1, 2020
 
January 15, 2020
 
$
0.484375

September 19, 2019
 
October 1, 2019
 
October 15, 2019
 
$
0.484375

June 19, 2019
 
July 1, 2019
 
July 15, 2019
 
$
0.484375

March 19, 2019
 
April 1, 2019
 
April 15, 2019
 
$
0.484375

Series E Preferred Stock:
 
 
 
 
 
 
December 17, 2019
 
January 1, 2020
 
January 15, 2020
 
$
0.468750

September 19, 2019
 
October 1, 2019
 
October 15, 2019
 
$
0.468750

June 19, 2019
 
July 1, 2019
 
July 15, 2019
 
$
0.468750

March 19, 2019
 
April 1, 2019
 
April 15, 2019
 
$
0.468750



Common Stock
Public Offering
On March 21, 2019, the Company completed a public offering of 18,000,000 shares of its common stock at a price of $13.76 per share. On March 22, 2019, an additional 2,700,000 shares were sold by the Company to the underwriters of the offering pursuant to an overallotment option. The net proceeds to the Company were approximately $284.5 million, after deducting offering expenses of approximately $0.3 million.
As of March 31, 2020, the Company had 273,528,243 shares of common stock outstanding. The following table presents a reconciliation of the common shares outstanding for the three months ended March 31, 2020 and 2019:
 
Number of common shares
Common shares outstanding, December 31, 2018
248,085,721

Issuance of common stock
24,377,530

Issuance of restricted stock (1)
363,353

Common shares outstanding, March 31, 2019
272,826,604

 
 
Common shares outstanding, December 31, 2019
272,935,731

Issuance of common stock
16,498

Issuance of restricted stock (1)
681,314

Repurchase of common stock
(105,300
)
Common shares outstanding, March 31, 2020
273,528,243

____________________
(1)
Represents shares of restricted stock granted under the Second Restated 2009 Equity Incentive Plan, net of forfeitures, of which 1,242,812 restricted shares remained subject to vesting requirements at March 31, 2020.

Distributions to Common Stockholders
On March 24, 2020, as a result of the volatile market conditions related to the COVID-19 pandemic, the Company announced that it had suspended its first quarter 2020 common stock dividend in order to preserve liquidity and long-term stockholder value. Subsequently, on April 6, 2020, the Company’s board of directors declared an interim common stock dividend of $0.05 per share. The interim dividend was paid on April 29, 2020 to common stockholders of record as of April 16, 2020. The following table presents cash dividends declared by the Company on its common stock from December 31, 2018 through March 31, 2020:
Declaration Date
 
Record Date
 
Payment Date
 
Cash Dividend Per Common Share
December 17, 2019
 
December 31, 2019
 
January 24, 2020
 
$
0.400000

September 19, 2019
 
September 30, 2019
 
October 28, 2019
 
$
0.400000

June 19, 2019
 
July 1, 2019
 
July 29, 2019
 
$
0.400000

March 19, 2019
 
March 29, 2019
 
April 29, 2019
 
$
0.470000



Dividend Reinvestment and Direct Stock Purchase Plan
The Company sponsors a dividend reinvestment and direct stock purchase plan through which stockholders may purchase additional shares of the Company’s common stock by reinvesting some or all of the cash dividends received on shares of the Company’s common stock. Stockholders may also make optional cash purchases of shares of the Company’s common stock subject to certain limitations detailed in the plan prospectus. The plan allows for the issuance of up to an aggregate of 3,750,000 shares of the Company’s common stock. As of March 31, 2020, 286,486 shares have been issued under the plan for total proceeds of approximately $5.1 million, of which 16,498 and 12,230 shares were issued for total proceeds of $0.1 million and $0.2 million during the three months ended March 31, 2020 and 2019, respectively.
Share Repurchase Program
The Company’s share repurchase program allows for the repurchase of up to an aggregate of 37,500,000 shares of the Company’s common stock. Shares may be repurchased from time to time through privately negotiated transactions or open market transactions, pursuant to a trading plan in accordance with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, or by any combination of such methods. The manner, price, number and timing of share repurchases are subject to a variety of factors, including market conditions and applicable SEC rules. The share repurchase program does not require the purchase of any minimum number of shares, and, subject to SEC rules, purchases may be commenced or suspended at any time without prior notice. The share repurchase program does not have an expiration date. As of March 31, 2020, a total of 12,174,300 shares had been repurchased by the Company under the program at an aggregate cost of $201.5 million; of these, 105,300 shares were repurchased at a total cost of $1.1 million during the three months ended March 31, 2020. No shares were repurchased during the three months ended March 31, 2019.
At-the-Market Offerings
The Company is party to an equity distribution agreement under which the Company is authorized to sell up to an aggregate of 35,000,000 shares of its common stock from time to time in any method permitted by law deemed to be an “at the market” offering as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act. As of March 31, 2020, 7,490,235 shares of common stock had been sold under the equity distribution agreements for total accumulated net proceeds of approximately $128.6 million, of which 3,665,300 shares were sold for net proceeds of $50.6 million during the three months ended March 31, 2019. No shares were sold during the three months ended March 31, 2020.
Accumulated Other Comprehensive Income
Accumulated other comprehensive income at March 31, 2020 and December 31, 2019 was as follows:
(in thousands)
March 31,
2020
 
December 31,
2019
Available-for-sale securities
 
 
 
Unrealized gains
$
505,389

 
$
730,043

Unrealized losses
(14,059
)
 
(40,643
)
Accumulated other comprehensive income
$
491,330

 
$
689,400



Reclassifications out of Accumulated Other Comprehensive Income
The Company reclassifies unrealized gains and losses on AFS securities in accumulated other comprehensive income to net loss upon the recognition of any other-than-temporary impairments, realized gains and losses on sales and provision for credit losses, net of income tax effects, as individual securities are impaired, sold or their allowance for credit losses is increased or decreased. The following table summarizes reclassifications out of accumulated other comprehensive income for the three months ended March 31, 2020 and 2019:
 
 
Affected Line Item in the Statements of Comprehensive (Loss) Income
 
Amount Reclassified out of Accumulated Other Comprehensive Income
 
 
 
 
Three Months Ended
(in thousands)
 
 
 
March 31,
 
 
 
 
2020
 
2019
Other-than-temporary impairments on AFS securities
 
Total other-than-temporary impairment losses
 
$

 
$
206

Realized (gains) losses on sales of certain AFS securities, net of tax
 
Loss on investment securities
 
(432,996
)
 
28,106

Provision for credit losses on AFS securities
 
Loss on investment securities
 
41,390

 

Total
 
 
 
$
(391,606
)
 
$
28,312